Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer

3 Nov 2019

Abstract excerpt

BACKGROUND & AIMS: Levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and cancer antigen 125 (CA-125) in blood are used as markers to determine the response of patients with cancer to therapy, but are not used to identify patients with pancreatic cancer. METHODS: We obtained blood samples from 504 patients undergoing pancreatic surveillance from 2002 through 2018 who did not develop...

Source

Identifiers

PMID: 31676359
DOI: 10.1016/j.cgh.2019.10.036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic CancerPMID 31676359Read ↗

Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer.Semantic proximity Read ↗

A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC.Semantic proximity Read ↗

Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9Semantic proximity Read ↗

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.Semantic proximity Read ↗

Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping.Semantic proximity Read ↗

A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.Semantic proximity Read ↗

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.Semantic proximity Read ↗

Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors.Semantic proximity Read ↗

Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based VariantsSemantic proximity Read ↗

The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.Semantic proximity Read ↗

Common and Rare Sequence Variants Influencing Tumor Biomarkers in Blood.Semantic proximity Read ↗

Genomic testing for pancreatic cancer in clinical practice as real-world evidenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.